Three cases of severe subfulminant hepatitis in heart-transplanted patients after nosocomial transmission of a mutant hepatitis B virus

Hepatology

Volumn 29, Issue 6, 1999, Pages 1876-1883

  Stuyver, L ^a   De Gendt, S ^a   Cadranel, J F ^a   Van Geyt, C ^a   Van Reybroeck, G ^a   Dorent, R ^a   Gandjbachkh, I ^a   Rosenheim, M ^a   Charlotte, F ^a   Opolon, P ^a   Huraux, J M ^a   Lunel, F ^a  

^a INNOGENETICS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B(E) ANTIGEN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FATALITY; GENE MUTATION; GENETIC ANALYSIS; HEART TRANSPLANTATION; HEPATITIS B; HEPATITIS B VIRUS; HOSPITAL INFECTION; HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

EID: 0033034003     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290614     Document Type: Article

References (35)

1. 1 Milich RM. Review: immune response to the hepatitis B virus: infection, animal models, vaccination. Viral Hepat Rev 1997 ; 3: 63–103.
2. 2 Hadziyannis SJ, Lieberman HM, Karvountis GG, Shafritz DA. Analysis of liver disease, nuclear HBcAg, viral replication and hepatitis B virus DNA in liver and serum of HBeAg versus anti‐HBe positive cariers of hepatitis B virus. Hepatology 1983 ; 3: 656–662. MEDLINE
3. 3 Brunetto MR, Stemler M, Bonino F, Schodel F, Oliveri F, Rizetto M. A new hepatitis B virus strain in patients with severe ante HBe positive chronic hepatitis B. J Hepatol 1990 ; 10: 258–261. MEDLINE
4. 4 Omata M, Ehata T, Yokosuka O, Hosada K, Ohto M. Mutations in the preCore region of hepatitis B virus in patients with fulminant and severe hepatitis. N Engl J Med 1991 ; 324: 1699–1704. MEDLINE
5. 5 Tanaka S, Yoshiba M, Iino S, Fukuda M, Nakao H, Tsuda F, Okamoto H, et al. A common‐source outbreak of fulminant hepatitis B in hemodialysis patients induced by precore mutant. Kidney Int 1995 ; 48: 1972–1978. MEDLINE
6. 6 Sato S, Suzuki K, Akahane Y, Akamatsu K, Akiyama K, Yunamura K, Tsuda F, et al. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann Intern Med 1995 ; 122: 241–248. MEDLINE
7. 7 Sterneck M, Günther S, Santantonio T, Fisher L, Broelsch CE, Greten H, Will H. Hepatitis B virus genomes of patients with fulminant hepatitis do not share a specific mutation. Hepatology 1996 ; 24: 300–306. MEDLINE
8. 8 Baumert TF, Pogers SA, Hasegawa K, Liang TJ. Two core promoter mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication. J Clin Invest 1996 ; 98: 2268–2276. MEDLINE
9. 9 Hasegawa K, Huang J, Rogers SA, Blum HE, Liang TJ. Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. J Virol 1994 ; 68: 1651–1659. MEDLINE
10. 10 Asahina Y, Enomoto N, Ogura Y, Sakuma I, Kurosaki M, Izumi N, Marumo F, et al. Complete nucleotide sequences of hepatitis B virus genomes associated with epidemic fulminant hepatitis. J Med Virol 1996 ; 48: 171–178. MEDLINE
11. 11 Pult I, Chourd T, Wieland S, Klemenz R, Yaniv M, Blum HE. A hepatitis B virus mutant with a hepatocyte nuclear factor 1 binding site emerging in transplant‐transmitted fulminant hepatitis B. Hepatology 1997 ; 25: 1507–1515. MEDLINE
12. 12 Pollicino T, Zanetti AR, Cacciola I, Petit MA, Smedile A, Campo S, Sagliocca L, et al. Pre‐S2 defective hepatitis B virus infection in patients with fulminant hepatitis. Hepatology 1997 ; 26: 495–499. MEDLINE
13. 13 Kaneko M, Uchida T, Moriyama M, Arakawa Y, Shikata T, Gotoh K, Mima S. Probable implication of mutations of the X open reading frame in the onset of fulminant hepatitis B. J Med Virol 1995 ; 47: 204–208. MEDLINE
14. 14 Ehata T, Omata M, Chuang WL, Yokosuka O, Ito Y, Hosada K, Ohto M. Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis. J Clin Invest 1993 ; 91: 1206–1213. MEDLINE
15. 15 Alexopoulou A, Karayiannis P, Hadziyannis SJ, Hou J, Pickering J, Luo K, Thomas HC. Whole genome analysis of hepatitis B virus from four cases of fulminant hepatitis: genetic variability and its potential role in disease pathogenecity. J Viral Hepat 1996 ; 3: 173–181. MEDLINE
16. 16 Sterneck M, Günther S, Gerlach J, Naoumov NV, Santantonio T, Fisher L, Rogiers X, et al. Hepatitis B virus sequence changes evolving in liver transplant recipients with fulminant hepatitis. J Hepatol 1997 ; 26: 754–764. MEDLINE
17. 17 Liang TJ, Hasegawa K, Munoz SJ, Shapiro CN, Yoffe B, McMahon BJ, Feng C, et al. Hepatitis B virus precore mutation and fulminant hepatitis in the United States: a polymerase chain reaction–based assay for the detection of specific mutations. J Clin Invest 1994 ; 93: 550–555. MEDLINE
18. 18 Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995 ; 13: 29–60. MEDLINE
19. 19 Thursz MR, Kwiatkowski D, Allsopp CEM, Geenwood BM, Thomas HC, Hill AVS. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 1995 ; 332: 1065–1069. MEDLINE
20. 20 Rosenheim M, Astagneau P, Dorent R, Lunel F, Stuyver L, Golliot F, Delcourt A, et al. Transmission nosocomiale de virus de l'hepatite B associée au cathétérisme veineux chez des transplantés cardiaques. Bulletin d'Épidémiologie Hebdomadaire 1997 ; 45: 201–203.
21. 21 Günther S, Li BC, Miska S, Krüger DH, Meisel H, Will H. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol 1995 ; 69: 5437–5444. MEDLINE
22. 22 Stuyver L, Wyseur A, van Arnem W, Hernandez F, Maertens G. Second‐generation line probe assay for hepatitis C virus genotypes. J Clin Microbiol 1996 ; 34: 2259–2266. MEDLINE
23. 23 Van Geyt C, De Gendt S, Rombout A, Wyseur A, Maertens G, Rossau R, Stuyver L. A line probe assay for hepatitis B virus genotypes. In: Schinazi RF, Sommadossi JP, Thomas HC, eds. Therapies for Viral Hepatitis ; International Medical Press, London. 1998 ; 139–145.
24. 24 Uchida T. Genetic variations of the hepatitis B virus and their clinical relevance. Microbiol Immunol 1993 ; 37: 425–439. MEDLINE
25. 25 Aye TT, Uchida T, Becker SO, Hirashima M, Shikata T, Komine F, Moriyama M, et al. Variations of hepatitis B virus preCore/Core gene sequences in acute and fulminant hepatitis B. Dig Dis Sci 1994 ; 39: 1281–1287. MEDLINE
26. 26 Akarca US, Lok ASF. Naturally occurring hepatitis B virus core gene mutations. Hepatology 1995 ; 22: 50–60. MEDLINE
27. 27 Böttcher B, Wynne SA, Crowther RA. Determination of the fold of the core protein of hepatitis B virus by electron microscopy. Nature 1997 ; 386: 88–91. MEDLINE
28. 28 Rehermann B, Pasquinelli C, Mosier SM, Chisari FV. Hepatitis B virus sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection. J Clin Invest 1995 ; 96: 1527–1534. MEDLINE
29. 29 Uchida T, Saitoh T, Shinzawa H. Mutations in the X region of the hepatitis B virus and their clinical implications. Pathol Int 1997 ; 47: 183–193. MEDLINE
30. 30 Kidd‐Ljunggren K, Öberg M, Kidd AH. The hepatitis B virus X gene: analysis of functional domain variation and gene phylogeny using multiple sequences. J Gen Virol 1995 ; 76: 2119–2130. MEDLINE
31. 31 Buckwold VE, Xu Z, Chen M, Yen TSB, Ou JH. Effect of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. J Virol 1996 ; 70: 5845–5851. MEDLINE
32. 32 Sterneck M, Kalinina T, Günther S, Fisher L, Santantonio T, Greten H, Will H. Functional analysis of HBV genomes from patients with fulminant hepatitis. Hepatology 1998 ; 28: 1390–1397. MEDLINE
33. 33 Takahashi K, Aoyama K, Ohno N, Iwata K, Akahane Y, Baba K, Yoshizawa H, et al. The precore/core promoter mutant (T1762A1764) of hepatitis B virus: clinical significance and an easy method for detection. J Gen Virol 1995 ; 76: 3159–3164. MEDLINE
34. 34 Li JS, Tong SP, Wen YM, Vivitski L, Zhang Q, Trepo C. Hepatitis B virus genotype A rarely circulates as an Hbe‐minus mutant: possible contribution of a single nucleotide in the precore region. J Virol 1993 ; 67: 5402–5410. MEDLINE
35. 35 Karayiannis P, Alexopoulou A, Hadziyannis SJ, Thursz M, Watts R, Seito S, Thomas HC. Fulminant hepatitis associated with hepatitis B virus e antigen‐negative: importance of host factors. Hepatology 1995 ; 22: 1628–1634. MEDLINE